MAPT and Alzheimer disease: We have also recently used in silico modelling based on known cryo-EM tau fibril structures to demonstrate that different tau PET tracers can show different preferences for and binding affinities to multiple binding sites on the tau fibrils in AD compared to CBD and PSP tissue [28–31].